Skip to main content
Gvs logo

Gvs — Investor Relations & Filings

Ticker · GVS ISIN · IT0005411209 LEI · 81560013EACB40B52D17 XMIL Manufacturing
Open in API
Filings indexed 568 across all filing types
Latest filing 2020-09-09 Earnings Release
Country IT Italy
Listing XMIL GVS

About Gvs

https://www.gvs.com/en/

GVS Group is a leading manufacturer of filters and filtration systems, specializing in the development and production of highly technological solutions. The company operates across three main divisions: Healthcare & Life Sciences, Energy & Mobility, and Health & Safety. Its products are utilized in a variety of critical applications, including MedTech, transfusion medicine, laboratory and scientific research, personal protection, and the automotive sector. GVS focuses on research, development, and innovation to provide advanced filtration solutions that support medical safety, scientific advancements, and personal and environmental protection.

Recent filings

Filing Released Lang Actions
Press release - GVS S.p.A._1H 2020 results
Earnings Release Classification · 99% confidence The document is explicitly titled 'PRESS RELEASE' and its subject is 'Press release - GVS S.p.A._1H 2020 results'. It details the consolidated financial results for the first half of 2020 (1H 2020), including Revenue, Adjusted EBITDA, Adjusted EBIT, and Net Profit, comparing them to the first half of 2019. This content structure—a formal announcement of period-specific financial performance highlights—is characteristic of an Earnings Release (ER). Although it mentions the availability of the 'Half Year Report' and a conference call, the document itself is the initial release of the results, not the comprehensive report (IR) or the transcript (CT). The length (28k chars) is substantial but the format is that of a press release summarizing key figures, fitting the ER definition best. H1 2020
2020-09-09 English
Comunicato stampa - GVS S.p.A._risultati 1H 2020
Earnings Release Classification · 99% confidence The document is explicitly titled 'COMUNICATO STAMPA' (Press Release) and its subject is 'GVS S.p.A. - CdA approva i risultati del primo semestre 2020' (GVS S.p.A. - Board of Directors approves the results for the first half of 2020). It presents key financial highlights (Ricavi, EBITDA, EBIT, Risultato Netto) for the first half of 2020 (1H 2020) and includes commentary from the CEO. This structure perfectly matches the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results, typically in a press release format, focusing on key figures before the full report is filed. Although it mentions the 'Relazione Finanziaria Semestrale' (Half-Year Financial Report) will be made available later, this document itself is the immediate announcement of those results. H1 2020
2020-09-09 Italian
Comunicato stampa: approvazione modifica alla Procedura per le Operazioni con le Parti Correlate e Politica di comunicazione informazioni finanziarie
Regulatory Filings Classification · 99% confidence The document is a press release ("Comunicato stampa") from GVS S.P.A. dated July 17, 2020. The subject matter concerns the approval of modifications to the Related Party Transactions Procedure and the adoption of a voluntary policy for communicating periodic financial information for the first and third quarters. This policy dictates the voluntary publication of quarterly financial highlights (key income statement and balance sheet data) within 45 days of the quarter's close. Since this document is announcing the adoption of a policy regarding the *communication* of periodic financial information (which is typically less comprehensive than a full Interim Report (IR) or Annual Report (10-K)), and it is a formal announcement, it fits best under the category of general Regulatory Filings (RNS) or potentially a specific type of announcement. However, the content is about establishing a new reporting/disclosure standard rather than releasing the actual financial data for a specific period or announcing a major corporate event like a merger or dividend. Given the options, and since it is a formal regulatory disclosure (indicated by 'Informazione Regolamentata' and 'REGEM' type) detailing governance/disclosure policy changes, RNS (Regulatory Filings) is the most appropriate general classification for this type of specific, non-standard announcement, as it doesn't fit ER, IR, 10-K, or MDA directly, but rather announces a procedural change related to financial communication.
2020-07-17 Italian
Errata corrige: Notifiche Internal Dealing
Director's Dealing Classification · 99% confidence The document is titled 'Errata corrige: Notifiche Internal Dealing' (Correction: Internal Dealing Notifications) and contains detailed tables regarding transactions made by persons discharging managerial responsibilities (PDMRs) at GVS S.p.A. Specifically, it details the 'Cessione' (Sale/Transfer) of ordinary shares by an executive (Amministratore Delegato) and associated persons. This directly corresponds to the definition of Director's Dealing (insider trades) as per the provided categories. The relevant code is DIRS.
2020-07-01 Italian
Notifiche Internal Dealing
Director's Dealing Classification · 99% confidence The document is an Italian 'Informazione Regolamentata' (Regulated Information) dated July 1, 2020. The subject ('Oggetto') is explicitly stated as 'Notifiche Internal Dealing' (Internal Dealing Notifications). The content details transactions (Cessione/Sale) involving shares of GVS S.p.A. carried out by individuals holding management positions ('Amministratore Delegato'). This directly corresponds to the definition of reporting personal share transactions by company directors and executives, which is classified as Director's Dealing (DIRS). The document is a formal notification of the transaction itself, not an announcement of a report.
2020-07-01 Italian
GVS S.p.A.: perfezionato il Closing dell’acquisizione di Haemonetics Puerto Rico, LLC
M&A Activity Classification · 95% confidence The document is a formal announcement from GVS S.p.A. dated June 29, 2020, regarding the completion ('Closing') of an acquisition (Haemonetics Puerto Rico, LLC). The structure, including the 'Informazione Regolamentata' header, the 'Oggetto' (Subject) detailing the transaction, and the body describing the financial terms (USD 15.5 million) and strategic rationale, strongly indicates a corporate action disclosure. This type of announcement, detailing a significant transaction like an acquisition, falls under the category of Capital/Financing Update (CAP) or potentially a general Regulatory Filing (RNS). Since the core subject is the financing/acquisition activity, 'CAP' is the most specific fit among the provided options, as it covers 'company fundraising, financing activities, or capital structure changes' (acquisitions are a major capital structure change). It is not an Earnings Release (ER), Interim Report (IR), or a general press release that just announces a report (RPA/RNS).
2020-06-29 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.